Exactech Company Profile (NASDAQ:EXAC)

About Exactech

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee implants, hip implants, biologics and spine, extremity implants and other products. Its other products segment includes surgical instruments, bone cement and other implant product lines. The Company offers knee implant systems, including Exactech Knee System and Optetrak Logic. It offers various products and services for the healing and regeneration of bone and soft tissue. Its hip solutions address the continuum of hip arthroplasty. It offers solutions for shoulders with traumatic injuries. Its joint replacement products are used to repair or replace joints that have deteriorated as a result of injury or disease.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Appliances & Equipment
Sub-Industry: Health Care Equipment
Exchange: NASDAQ
Symbol: EXAC
CUSIP: 30064E10

Key Metrics:

Previous Close: $27.34
50 Day Moving Average: $27.81
200 Day Moving Average: $24.71
52-Week Range: $16.11 - $28.66
Trailing P/E Ratio: 24.63
Foreward P/E Ratio: 20.37
P/E Growth: 2.66
Market Cap: $386.83M
Outstanding Shares: 14,149,000
Beta: 0.84

Profitability:

Net Margins: 6.32%
Return on Equity: 6.84%
Return on Assets: 5.54%

Debt:

Debt-to-Equity Ratio: 0.08%
Current Ratio: 4.68%
Quick Ratio: 2.24%

Additional Links:

Companies Related to Exactech:

Consensus Ratings for Exactech (NASDAQ:EXAC) (?)

Ratings Breakdown:	1 Hold Rating, 1 Buy Rating
Consensus Rating:	Buy (Score: 2.50)
Consensus Price Target:	$23.00 (15.72% downside)

Analysts' Ratings History for Exactech (NASDAQ:EXAC)

Show:

Date	Firm	Action	Rating	Price Target
4/13/2016	Robert W. Baird	Upgrade	Neutral -> Outperform	$21.00 -> $26.00
10/28/2015	Northland Securities	Lower Price Target	Market Perform	$22.00 -> $20.00
7/29/2015	Canaccord Genuity	Reiterated Rating	Hold	$22.00
3/19/2015	Gabelli	Initiated Coverage	Buy	$37.00

(Data available from 9/27/2014 forward)

Earnings History for Exactech (NASDAQ:EXAC)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/25/2016
8/1/2016	Q216	$0.30	$0.31	$64.18 million	$66.10 million	View	N/A
4/26/2016	Q116	$0.29	$0.31	$63.63 million	$65.30 million	View	N/A
2/16/2016	Q415	$0.28	$0.29	$61.29 million	$62.70 million	View	Listen
10/27/2015	Q315	$0.23	$0.20	$58.46 million	$56.20 million	View	Listen
7/28/2015	Q215	$0.27	$0.26	$62.13 million	$61.50 million	View	Listen
4/28/2015	Q115	$0.30	$0.29	$63.71 million	$61.40 million	View	N/A
2/17/2015	Q414	$0.33	$0.36	$63.30 million	$63.30 million	View	N/A
10/21/2014	Q314	$0.25	$0.21	$58.60 million	$57.90 million	View	N/A
7/28/2014	Q214	$0.30	$0.30	$63.80 million	$63.92 million	View	N/A
4/21/2014	Q114	$0.29	$0.30	$63.05 million	$63.30 million	View	N/A
2/19/2014	Q413	$0.31	$0.33	$63.20 million	$61.60 million	View	N/A
10/22/2013	Q313	$0.21	$0.23	$55.36 million	$55.70 million	View	N/A
7/23/2013	Q2 2013	$0.25	$0.27	$58.42 million	$60.60 million	View	N/A
2/26/2013	Q4 2012	$0.28	$0.29	$58.20 million	$59.30 million	View	N/A
10/30/2012	Q312	$0.17	$0.19	$50.20 million	$51.30 million	View	N/A
7/31/2012		$0.23	$0.23			View	N/A
5/1/2012		$0.23	$0.25			View	N/A
2/28/2012		$0.25	$0.18			View	N/A
11/1/2011		$0.20	$0.15			View	N/A
8/2/2011		$0.26	$0.28			View	N/A
5/3/2011		$0.27	$0.28			View	N/A
2/28/2011		$0.23	$0.23			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Exactech (NASDAQ:EXAC)

Current Year EPS Consensus Estimate: $1.18 EPS
Next Year EPS Consensus Estimate: $1.34 EPS

Dividend History for Exactech (NASDAQ:EXAC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Exactech (NASDAQ:EXAC)

Insider Ownership Percentage: 29.80%
Institutional Ownership Percentage: 65.08%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/25/2016	Fern Watts	Director	Sell	1,100	$27.68	$30,448.00
8/22/2016	Bruce E Thompson	SVP	Sell	1,433	$27.97	$40,081.01
8/19/2016	David W Petty	CEO	Sell	3,550	$27.75	$98,512.50
7/1/2016	Joel C Phillips	CFO	Sell	3,000	$26.75	$80,250.00
6/8/2016	Gary J Miller	EVP	Sell	9,800	$25.16	$246,568.00
6/7/2016	Bruce E Thompson	SVP	Sell	2,000	$25.07	$50,140.00
6/3/2016	James G Binch	Director	Sell	600	$24.86	$14,916.00
6/2/2016	Gary J Miller	EVP	Sell	3,381	$25.11	$84,896.91
5/25/2016	Gary J Miller	EVP	Sell	9,319	$25.10	$233,906.90
5/18/2016	Gary J Miller	EVP	Sell	9,664	$24.37	$235,511.68
5/9/2016	Joel C Phillips	CFO	Sell	3,900	$23.13	$90,207.00
5/5/2016	James G Binch	Director	Sell	1,870	$23.00	$43,010.00
5/3/2016	Fern Watts	Director	Sell	2,000	$22.76	$45,520.00
4/29/2016	Betty A Petty	VP	Sell	18,000	$22.65	$407,700.00
4/27/2016	Gary J Miller	EVP	Sell	9,851	$24.06	$237,015.06
4/26/2016	Gary J Miller	EVP	Sell	7,985	$23.11	$184,533.35
4/25/2016	Gary J Miller	EVP	Sell	4,725	$23.14	$109,336.50
3/31/2016	Gary J Miller	EVP	Sell	7,000	$19.95	$139,650.00
3/10/2016	Joel C Phillips	CFO	Sell	2,000	$18.58	$37,160.00
3/8/2016	Betty A Petty	VP	Sell	15,964	$19.06	$304,273.84
3/7/2016	Donna M Edwards	VP	Sell	10,000	$18.85	$188,500.00
3/3/2016	Gary J Miller	EVP	Sell	7,017	$19.23	$134,936.91
3/3/2016	William B Locander	Director	Sell	2,435	$19.25	$46,873.75
12/10/2015	James G Binch	Director	Sell	1,500	$17.03	$25,545.00
12/9/2015	Fern Watts	Director	Sell	1,200	$17.32	$20,784.00
12/1/2015	Bruce E. Thompson	SVP	Sell	21,904	$17.57	$384,853.28
11/24/2015	Bruce E. Thompson	SVP	Sell	900	$17.75	$15,975.00
9/1/2015	Bruce E. Thompson	SVP	Sell	2,107	$19.45	$40,981.15
5/28/2015	Joel C Phillips	CFO	Sell	5,000	$21.76	$108,800.00
5/20/2015	William B Locander	Director	Sell	3,350	$21.50	$72,025.00
5/18/2015	Fern Watts	Director	Sell	2,200	$21.21	$46,662.00
5/4/2015	Joel C Phillips	CFO	Sell	2,700	$21.67	$58,509.00
3/20/2015	Gary J Miller	EVP	Sell	32,800	$24.95	$818,360.00
2/24/2015	R William Petty	Chairman	Sell	45,067	$23.08	$1,040,146.36
2/2/2015	Betty A Petty	VP	Sell	7,500	$20.74	$155,550.00
1/8/2015	Gary J Miller	EVP	Sell	4,145	$23.17	$96,039.65
12/3/2014	Gary J Miller	EVP	Sell	5,000	$21.83	$109,150.00
11/25/2014	Betty A Petty	Major Shareholder	Sell	12,500	$21.86	$273,250.00
11/25/2014	Bruce E Thompson	SVP	Sell	6,500	$22.05	$143,325.00
10/31/2014	Joel C Phillips	CFO	Sell	5,000	$21.44	$107,200.00
9/5/2014	R William Petty	Major Shareholder	Sell	25,000	$23.68	$592,000.00
8/25/2014	Albert H Burstein	Director	Sell	8,852	$23.73	$210,057.96
7/1/2014	Gary J Miller	EVP	Sell	12,392	$26.21	$324,794.32
6/26/2014	Gary J Miller	EVP	Sell	1,894	$25.06	$47,463.64
6/25/2014	Gary J Miller	EVP	Sell	16,356	$25.33	$414,297.48
6/10/2014	Joel C Phillips	CFO	Sell	5,000	$24.77	$123,850.00
6/5/2014	Bruce E Thompson	SVP	Sell	1,667	$23.50	$39,174.50
6/5/2014	Joel C Phillips	CFO	Sell	5,000	$23.21	$116,050.00
5/29/2014	Bruce E Thompson	SVP	Sell	1,588	$23.00	$36,524.00
5/12/2014	David Petty	CEO	Sell	10,287	$20.99	$215,924.13
5/8/2014	David Petty	CEO	Sell	7,976	$21.51	$171,563.76
4/24/2014	Bruce Thompson	SVP	Sell	2,412	$23.78	$57,357.36
4/23/2014	William Locander	Director	Sell	4,500	$23.18	$104,310.00
2/28/2014	William Locander	Director	Sell	1,819	$23.16	$42,128.04
12/5/2013	R William Petty	CEO	Sell	10,000	$23.67	$236,700.00
11/12/2013	Bruce Thompson	SVP	Sell	3,079	$23.35	$71,894.65
8/22/2013	William Locander	Director	Sell	1,521	$19.05	$28,975.05
7/15/2013	Gary J Miller	EVP	Sell	10,250	$20.07	$205,717.50
7/8/2013	Gary J Miller	EVP	Sell	1,000	$20.00	$20,000.00
6/17/2013	Gary J Miller	EVP	Sell	8,125	$18.98	$154,212.50
6/5/2013	R William Petty	CEO	Sell	3,885	$18.00	$69,930.00
6/4/2013	R William Petty	CEO	Sell	14,257	$18.01	$256,768.57
5/28/2013	R William Petty	CEO	Sell	20,000	$18.21	$364,200.00
5/22/2013	R William Petty	CEO	Sell	11,493	$18.13	$208,368.09
5/17/2013	R William Petty	CEO	Sell	17,472	$18.05	$315,369.60
5/16/2013	R William Petty	CEO	Sell	22,893	$18.22	$417,110.46
5/9/2013	R William Petty	CEO	Sell	10,000	$18.25	$182,500.00
5/8/2013	David W Petty	President	Sell	8,000	$18.35	$146,800.00
12/4/2012	R William Petty	CEO	Sell	14,048	$16.29	$228,841.92

(Data available from 1/1/2013 forward)

Latest Headlines for Exactech (NASDAQ:EXAC)

Date	Headline
	Platelet Rich Plasma Market: Extensive Application in Cosmetic Industry & Treatment of Various Diseases (NASDAQ:EXAC) www.digitaljournal.com - September 26 at 5:04 PM
	Platelet Rich Plasma Market - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023 (NASDAQ:EXAC) www.prnewswire.com - September 24 at 4:41 PM
	Statement - H1 2016 results (NASDAQ:EXAC) www.publicnow.com - September 23 at 4:40 PM
	Exactech Has Returned 38.9% Since SmarTrend Recommendation (EXAC) (NASDAQ:EXAC) www.mysmartrend.com - September 21 at 9:08 AM
	Knee Reconstruction Devices Market worth 7.94 Billion USD by 2020 (NASDAQ:EXAC) www.emailwire.com - September 17 at 4:47 PM
	Global Hip & Knee Reconstruction Devices Market 2016 Share, Trend, Segmentation and Forecast to 2020 (NASDAQ:EXAC) world.einnews.com - September 14 at 5:01 PM
	Exactech Up 33.3% Since SmarTrend Uptrend Call (EXAC) (NASDAQ:EXAC) www.mysmartrend.com - September 14 at 5:01 PM
	Exactech, Inc. – Value Analysis (NASDAQ:EXAC) : September 14, 2016 (NASDAQ:EXAC) www.capitalcube.com - September 14 at 5:01 PM
	Exactech, Inc. breached its 50 day moving average in a Bullish Manner : EXAC-US : September 13, 2016 (NASDAQ:EXAC) www.capitalcube.com - September 13 at 9:46 AM
	Global Extremities Market 2016: Industry Demand, Consumption and Research to 2021 (NASDAQ:EXAC) qwtjlive.com - September 11 at 9:25 AM
	Exactech Announces Investor Presentation at Baird Global Healthcare Conference (NASDAQ:EXAC) finance.yahoo.com - September 6 at 4:51 PM
	Orthobiologics Market : Detailed Overview & Competitive Landscape (NASDAQ:EXAC) www.openpr.com - September 2 at 4:52 PM
	ETF’s with exposure to Exactech, Inc. : September 1, 2016 (NASDAQ:EXAC) www.capitalcube.com - September 1 at 4:49 PM
	This Little-Known Orthopedic-Device Stock Is Delivering Huge Returns (NASDAQ:EXAC) www.thestreet.com - August 29 at 4:52 PM
	Global Bone Graft Substitute Industry (NASDAQ:EXAC) www.bizjournals.com - August 25 at 4:57 PM
	Global Knee Implants Market Is Projected to Reach More Than US$ 7 Billion by 2021; Finds New Report (NASDAQ:EXAC) www.sbwire.com - August 24 at 4:52 PM
	Global Spinal Fixation Industry Forecasts (2016-2021) by Market Size (Volume and Value), Sales Price, & Gross Margin (NASDAQ:EXAC) empowerednews.net - August 24 at 5:28 AM
	Global Orthopedic Devices Market to Reach US$41.2 billion in 2019 (NASDAQ:EXAC) reports.pr-inside.com - August 22 at 5:00 PM
	Shares of EXAC Up 37.3% Since Uptrend Call on Shares (NASDAQ:EXAC) www.mysmartrend.com - August 19 at 4:52 PM
	Global Hip Prosthesis Market to Grow at a CAGR of 2.57% During the Period 2016 - 2020; Finds New Report (NASDAQ:EXAC) www.sbwire.com - August 13 at 4:51 PM
	Bone Grafts Market : Information, Figures and Analytical Insights 2015 – 2021 (NASDAQ:EXAC) reports.pr-inside.com - August 12 at 4:59 PM
	Exactech Up 41.2% Since SmarTrend Uptrend Call (EXAC) (NASDAQ:EXAC) www.mysmartrend.com - August 12 at 4:59 PM
	Platelet Concentration Systems Market Value Share, Supply Demand 2016-2026 (NASDAQ:EXAC) reports.pr-inside.com - August 11 at 5:05 PM
	Exactech, Inc. :EXAC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:EXAC) www.capitalcube.com - August 10 at 5:10 PM
	Manufacturing Plants Construction in Myanmar to 2020: Market Databook - New Market Report (NASDAQ:EXAC) reports.pr-inside.com - August 9 at 9:14 PM
	EXACTECH INC Files SEC form 10-Q, Quarterly Report (NASDAQ:EXAC) biz.yahoo.com - August 9 at 3:38 PM
	Exacompta Clairefontaine SA :EXAC-FR: Earnings Analysis: For the six months ended December 31, 2015 : August 8, 2016 (NASDAQ:EXAC) www.capitalcube.com - August 8 at 9:44 AM
	Bone Cement 2016 Market Share,Supply,Consupmtion and Market Opportunities Research Report Forecasting to 2020 (NASDAQ:EXAC) www.medgadget.com - August 5 at 10:12 PM
	Edited Transcript of EXAC earnings conference call or presentation 2-Aug-16 2:00pm GMT (NASDAQ:EXAC) finance.yahoo.com - August 2 at 10:33 PM
	EXACTECH INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S (NASDAQ:EXAC) biz.yahoo.com - August 2 at 9:44 AM
	Exactech beats by $0.01, beats on revenue (NASDAQ:EXAC) seekingalpha.com - August 1 at 5:19 PM
	Exactech posts 2Q profit (NASDAQ:EXAC) sg.finance.yahoo.com - August 1 at 4:50 PM
	Q2 2016 Exactech Inc Earnings Release - After Market Close (NASDAQ:EXAC) biz.yahoo.com - August 1 at 7:07 AM
	Medical Instrument Q2 Earnings on Aug 1: AVGR, EXAC, GKOS (NASDAQ:EXAC) finance.yahoo.com - July 29 at 9:57 AM
	Knee Replacement Market Revenue and Value Chain 2015-2025 (NASDAQ:EXAC) www.openpr.com - July 23 at 4:46 PM
	Naming rights pull in big money, exposure (NASDAQ:EXAC) www.gatorsports.com - July 20 at 6:11 PM
	Hip & Knee Reconstruction Devices Market Size, Analysis, Report, Trends, Share, Opportunities and Forecast To 2022 (NASDAQ:EXAC) itbusinessnet.com - July 17 at 9:28 AM
	Now Available – Worldwide Knee Replacement Market Report 2015-2025 (NASDAQ:EXAC) empowerednews.net - July 15 at 6:49 AM
	Exactech Inc. (EXAC) Hits New 52-week High During July 12 Session (NASDAQ:EXAC) www.equities.com - July 14 at 5:03 PM
	Exactech Schedules Second Quarter 2016 Earnings Release and Conference Call (NASDAQ:EXAC) finance.yahoo.com - July 14 at 9:09 AM
	Increasing Musculoskeletal Therapy Count Expected to Push Global Orthobiologics Market Innovations, Expected to Reach US$5.52 bn by 2019 (NASDAQ:EXAC) www.openpr.com - July 6 at 9:40 AM
	Orthobiologics 2016 World Market Indicators,Research Methodology,Landscape,Geographical Segmentation Research Report Forecast to 2020 (NASDAQ:EXAC) www.newsmaker.com.au - July 1 at 4:56 PM
	Global Shoulder Replacement – Pipeline Consumption 2016 :BioPoly RS , Exactech, Inc., Imperial College London (NASDAQ:EXAC) www.medgadget.com - June 29 at 4:53 PM
	Recent Study on Global Knee Reconstruction Devices Market is Expected to Dive at Highest Growing CAGR (NASDAQ:EXAC) www.medgadget.com - June 24 at 11:45 AM
	Exactech Inc. (EXAC) is Trading Higher on Unusual Volume for June 21 (NASDAQ:EXAC) www.equities.com - June 22 at 10:08 PM
	Platelet Concentration Systems Market Value Share and Key Trends 2016-2026 (NASDAQ:EXAC) www.openpr.com - June 21 at 4:44 PM
	ETF’s with exposure to Exactech, Inc. : June 21, 2016 (NASDAQ:EXAC) www.capitalcube.com - June 21 at 12:58 PM
	Exactech Announces Full Launch of Acapella® One Cervical Spacer System (NASDAQ:EXAC) finance.yahoo.com - June 20 at 9:00 AM
	Exactech Inc. (EXAC) Hits New 52-week High During June 16 Session (NASDAQ:EXAC) www.equities.com - June 18 at 4:36 PM
	Exactech Inc. (EXAC) Hits New 52-week High During June 14 Session (NASDAQ:EXAC) www.equities.com - June 16 at 4:57 PM